
Ecopia BioSciences Inc. — Investor Relations & Filings
Ecopia BioSciences Inc. is a biotechnology company specializing in the research and development of novel therapeutic solutions, primarily focusing on drug discovery. The company's core strategy involves identifying and developing anticancer agents derived from microorganisms, recognized as a historically prolific source of pharmaceutical compounds. Ecopia's pipeline includes lead drug candidate ECO-4601, an anticancer compound that has reached key patent milestones, and other candidates such as CAPTAT-414. The company leverages specialized R&D platforms for the development of organism and botanical-derived drugs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Other securityholders documents - English.pdf | 2007-04-11 | English | |
| Material change report - French.pdf | 2007-01-15 | English | |
| Material change report - English.pdf | 2007-01-05 | English | |
| Material change report - English.pdf | 2006-09-05 | English | |
| Material change report - English.pdf | 2006-07-14 | English | |
| Material change report - English.pdf | 2006-05-24 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Vcanbio Cell & Gene Engineering Corp., Ltd
Focuses on stem cell bio-banking, genetic testing, and cell…
|
600645 | CN | Professional, scientific and te… |
|
VECTUS BIOSYSTEMS LIMITED
Develops therapeutics to reverse fibrosis and hypertension …
|
VBS | AU | Professional, scientific and te… |
|
Veradermics, Inc
Clinical-stage biopharmaceutical company developing medical…
|
MANE | US | Professional, scientific and te… |
|
Vera Therapeutics, Inc.
Clinical-stage biotech developing treatments for immunologi…
|
VERA | US | Professional, scientific and te… |
|
Veritas In Silico Inc.
A drug discovery company developing mRNA-targeting therapeu…
|
130A | JP | Professional, scientific and te… |
|
ViGenCell Inc.
Develops immune cell therapies to treat cancer and other in…
|
308080 | KR | Professional, scientific and te… |
|
Viking Therapeutics, Inc.
Clinical-stage biopharma developing therapies for metabolic…
|
VKTX | US | Professional, scientific and te… |
|
Vimta Labs Ltd.
Contract research and testing organization for life science…
|
VIMTALABS | IN | Professional, scientific and te… |
|
Vinext S.p.A.
Develops sustainable technology for the oenology and agri-f…
|
VNXT | IT | Professional, scientific and te… |
|
Virax Biolabs Group Ltd
Biotechnology company specializing in immune response detec…
|
VRAX | US | Professional, scientific and te… |
Ecopia BioSciences Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/45024/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=45024 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=45024 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=45024 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 45024}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ecopia BioSciences Inc. (id: 45024)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.